A recent study from the Icahn School of Medicine at Mount Sinai describes a newly-discovered SARS-CoV-2 (COVID-19) detection method that used SARS-CoV-2 spike protein DNA optimized and synthesized by GENEWIZ gene synthesis services.
GENEWIZ is proud to have provided gene synthesis services to support researchers developing a two-fold approach that uses structure-based virtual and high-throughput screening assays to test drug candidates and other pharmacologically active compounds for inhibiting SARS-CoV-2: Mpro.
Researchers from Dr. Cheng-Feng Qin’s lab used GENEWIZ gene synthesis services to develop a new COVID-19 vaccine consisting of mRNA that encodes the receptor-binding domain of the SARS-CoV-2 spike protein.
